64 results
8-K
EX-10.2
URGN
UroGen Pharma Ltd.
8 Aug 24
Departure of Directors or Certain Officers
4:30pm
, in a form approved by the Company (or the designated broker), designate a third party who, on the death of the Participant, will thereafter be entitled … of such a designation, upon the death of the Participant, the executor or administrator of the Participant’s estate will be entitled to exercise the Option or SAR
424B5
URGN
UroGen Pharma Ltd.
18 Jun 24
Prospectus supplement for primary offering
5:05pm
, and patients who have had two to four procedures have an estimated 14% greater risk of death than patients who have only had one procedure.
Corporate … earlier death, resignation or removal by a vote of the majority of the aggregate voting power of the Company at a general meeting of our shareholders
424B5
yi7m6rywg
17 Jun 24
Prospectus supplement for primary offering
4:19pm
8-K
onkjm5tp6q 76
13 Jun 24
Regulation FD Disclosure
10:51am
8-K
EX-99.1
wkqsgs5f5 hlcgofu
13 Jun 24
Regulation FD Disclosure
10:51am
8-K
EX-99.1
g9s 20shm
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
1fmqjypst3p185z8knx3
7 Feb 24
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
b31ho3
14 Nov 23
UroGen Pharma Reports Third Quarter 2023 Financial Results
12:00am